Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-06-23 8:47 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner |
0 | $0 | 8,739,158 (Indirect) |
View |
Ownership |
2021-06-23 8:44 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Castle John C. Chief Data Scientist |
0 | $0 | 251,594 (Direct) |
View |
Ownership |
2021-06-23 8:40 pm |
N/A 2030-08-13 |
Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director |
0 | $0 | 35,931 (Direct) |
View |
Ownership |
2021-06-23 8:38 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus See Remarks |
0 | $0 | 1,741,811 (Direct) |
View |
Ownership |
2021-06-23 8:35 pm |
N/A 2031-04-12 |
Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer |
0 | $0 | 387,069 (Direct) |
View |
Ownership |
2021-06-23 8:32 pm |
N/A 2030-08-13 |
Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Technology Officer |
0 | $0 | 290,301 (Direct) |
View |
Ownership |
2021-06-23 8:29 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
0 | $0 | 8,739,158 (Direct) |
View |
Ownership |
2021-06-23 6:09 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund II LP 10% Owner |
0 | $0 | 2,602,200 (Indirect) |
View |